Geoffrey Y. Ku, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of immune checkpoint inhibition in gastric and esophageal cancers.
Geoffrey Y. Ku, MD
Articles by Geoffrey Y. Ku, MD
Latest Updated Articles
The Future of Immune Checkpoint Inhibition in Gastric and Esophageal CancersPublished: February 2nd 2017 | Updated: